「may」の検索結果
19件：6～10件目を表示
-
MytearV | OTC Products, etc. | Products | SENJU Pharmaceutical
4 times a day. < Precautions regarding dosage and directions > Excessive use of this medicine may cause abnormal brightness or even hyperemia. Children are permitted to use this medicine only un...
https://www.senju.co.jp/english/products/mytearv.html -
General Announcement: May 9, 2024 Senju Pharmaceutical Co., Ltd. Senju announces initiation of Phase III Clinical Trials in Japan for “SJP-0008” for the treatment of Central Retinal Artery Occlusion S...
https://www.senju.co.jp/system/files/content_news/2024-05/ENG_20240509.pdf -
General Announcement: May 9, 2024 Senju Pharmaceutical Co., Ltd. Senju announces initiation of Phase III Clinical Trials in Japan for “SJP-0008” for the treatment of Central Retinal Artery Occlusion S...
https://www.senju.co.jp/system/files/content_news/2024-05/ENG_20240509_0.pdf -
Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica
te any changes to the information posted on this website. However, please note that the information may differ from the up-to-date information depending on when it is updated. Disclaimer This website ...
http://www.senju.co.jp/english/rd/trial.html -
Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica
te any changes to the information posted on this website. However, please note that the information may differ from the up-to-date information depending on when it is updated. Disclaimer This website ...
https://www.senju.co.jp/english/rd/trial.html